Cargando…

The Role of EREG/EGFR Pathway in Tumor Progression

Aberrant activation of the epidermal growth factor receptor (EGFR/ERBB1) by erythroblastic leukemia viral oncogene homolog (ERBB) ligands contributes to various tumor malignancies, including lung cancer and colorectal cancer (CRC). Epiregulin (EREG) is one of the EGFR ligands and is low expressed in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Wan-Li, Feng, Po-Hao, Lee, Kang-Yun, Chen, Kuan-Yuan, Sun, Wei-Lun, Van Hiep, Nguyen, Luo, Ching-Shan, Wu, Sheng-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657471/ https://www.ncbi.nlm.nih.gov/pubmed/34884633 http://dx.doi.org/10.3390/ijms222312828

Ejemplares similares

Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma
por: Li, Mengwei, et al.
Publicado: (2022)

Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter
por: Qu, X, et al.
Publicado: (2016)

Polymorphism in the EREG gene confers susceptibility to tuberculosis
por: Cao, Wen, et al.
Publicado: (2019)

BMP7 and EREG Contribute to the Inductive Potential of Dental Mesenchyme
por: Gao, Bo, et al.
Publicado: (2015)

EREG is a risk factor for the prognosis of patients with cervical cancer
por: Li, Tianye, et al.
Publicado: (2023)

Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma
por: Van Hiep, Nguyen, et al.
Publicado: (2022)

Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma
por: Van Hiep, Nguyen, et al.
Publicado: (2022)

Syringic acid mitigates isoproterenol‐induced cardiac hypertrophy and fibrosis by downregulating Ereg
por: Han, Xiongyi, et al.
Publicado: (2022)

Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction
por: Job, Sylvie, et al.
Publicado: (2019)

RHOA GTPase Controls YAP-Mediated EREG Signaling in Small Intestinal Stem Cell Maintenance
por: Liu, Ming, et al.
Publicado: (2017)

Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer
por: Lee, Michael S, et al.
Publicado: (2016)

Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction
por: Jehl, Aude, et al.
Publicado: (2023)

NONHSAT021545/miR-330-3p/EREG: A Cooperative Axis in Breast Cancer Prognosis and Treatment
por: Zhang, Yunkun, et al.
Publicado: (2023)

EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy
por: Liu, Shuli, et al.
Publicado: (2020)

miR-215 Targeting Novel Genes EREG, NIPAL1 and PTPRU Regulates the Resistance to E.coli F18 in Piglets
por: Dai, Chao-Hui, et al.
Publicado: (2020)

Depletion of EREG enhances the osteo/dentinogenic differentiation ability of dental pulp stem cells via the p38 MAPK and Erk pathways in an inflammatory microenvironment
por: Ran, Ran, et al.
Publicado: (2021)

Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma
por: Burgy, Mickaël, et al.
Publicado: (2021)

EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma
por: Zhou, Yujie, et al.
Publicado: (2023)

p130Cas Is Correlated with EREG Expression and a Prognostic Factor Depending on Colorectal Cancer Stage and Localization Reducing FOLFIRI Efficacy
por: Kumbrink, Jörg, et al.
Publicado: (2021)

The Role of EREG, PTPN1, and SERPINB7 Genes in the Pathogenesis of Psoriasis: May SERPINB7 Be Protective and a Marker of Severity for Psoriasis?
por: Ayvaz, Havva Hilal, et al.
Publicado: (2022)

Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment
por: Foggetti, Giorgia, et al.
Publicado: (2022)

Epiregulin (EREG) and Myocardin Related Transcription Factor A (MRTF-A) Form a Feedforward Loop to Drive Hepatic Stellate Cell Activation
por: Wu, Xiaoyan, et al.
Publicado: (2021)

Nicotinic-nAChR signaling mediates drug resistance in lung cancer
por: Cheng, Wan-Li, et al.
Publicado: (2020)

S100A9(+) MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB
por: Feng, Po-Hao, et al.
Publicado: (2018)

Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB
por: Feng, Po-Hao, et al.
Publicado: (2018)

LncRNA CYP4A22-AS1 promotes the progression of lung adenocarcinoma through the miR-205-5p/EREG and miR-34c-5p/BCL-2 axes
por: Dong, Liyao, et al.
Publicado: (2023)

Fucoidan–Fucoxanthin Ameliorated Cardiac Function via IRS1/GRB2/ SOS1, GSK3β/CREB Pathways and Metabolic Pathways in Senescent Mice
por: Chang, Po-Ming, et al.
Publicado: (2019)

EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR
por: Wang, Anbang, et al.
Publicado: (2020)

MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma
por: Zou, Chen-Dan, et al.
Publicado: (2015)

Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2(nd) Line Cetuximab-Based Therapy of Colorectal Cancer Patients
por: Saridaki, Zacharenia, et al.
Publicado: (2011)

Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival
por: Lo, H-W, et al.
Publicado: (2006)

Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway
por: Bajpai, Deepti, et al.
Publicado: (2021)

TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma
por: Hsieh, Cheng-Han, et al.
Publicado: (2020)

Bispecific Antibody Conjugated Manganese-Based Magnetic Engineered Iron Oxide for Imaging of HER2/neu- and EGFR-Expressing Tumors
por: Wu, Shou-Cheng, et al.
Publicado: (2016)

Linear Ubiquitination Mediates EGFR-Induced NF-κB Pathway and Tumor Development
por: Hua, Fang, et al.
Publicado: (2021)

Potential Impacts of Interleukin-17A Promoter Polymorphisms on the EGFR Mutation Status and Progression of Non-Small Cell Lung Cancer in Taiwan
por: Lee, Kai-Ling, et al.
Publicado: (2021)

Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival
por: Su, Yu-Li, et al.
Publicado: (2020)

NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation
por: Zhang, Peng, et al.
Publicado: (2023)

Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of the Phase III AIO KRK-0207 Trial
por: Stintzing, Sebastian, et al.
Publicado: (2018)

Improved survival in patients with unresectable stage III EGFR ‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors
por: Wang, Sheng‐Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jlvcs0lq5krg4iv413hoh6m6da